Vidipha Central Pharmaceutical JSC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000VDP2
VND
54,000.00
-900 (-1.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
9,85,636.69
9,34,486.82
10,19,316.69
10,07,796.14
7,85,355.58
6,86,480.94
6,19,252.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,85,636.69
9,34,486.82
10,19,316.69
10,07,796.14
7,85,355.58
6,86,480.94
6,19,252.70
Raw Material Cost
7,35,565.94
7,11,853.73
7,53,442.19
7,58,407.72
6,00,764.99
5,33,198.45
5,02,883.66
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,36,069.39
1,17,507.55
1,38,210.67
1,44,034.60
1,24,839.19
87,732.58
74,075.98
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10,446.77
14,848.78
27,558.63
20,545.54
12,938.16
8,839.27
5,803.13
Selling and Distribution Expenses
1,53,059.30
1,38,507.83
1,65,566.34
1,56,072.81
1,28,501.34
93,339.33
73,154.89
Other Expenses
-14,651.62
-13,235.63
-16,576.93
-16,458.01
-13,777.73
-9,657.19
-7,987.91
Total Expenditure (Excl Depreciation)
8,88,625.24
8,50,361.56
9,19,008.53
9,14,480.53
7,29,266.34
6,26,537.78
5,76,038.54
Operating Profit (PBDIT) excl Other Income
97011.5
84125.3
100308.2
93315.59999999999
56089.2
59943.2
43214.2
Other Income
11,232.86
23,335.81
28,967.44
23,200.41
34,693.47
12,322.50
19,207.16
Operating Profit (PBDIT)
1,23,981.08
1,35,570.12
1,55,716.75
1,34,656.91
1,07,281.79
88,378.63
76,809.89
Interest
10,446.77
14,848.78
27,558.63
20,545.54
12,938.16
8,839.27
5,803.13
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
2,50,070.75
2,22,633.09
2,65,874.50
2,49,388.42
1,84,590.58
1,53,282.49
1,16,369.05
Depreciation
29,989.31
30,368.54
27,589.54
20,797.82
17,233.42
16,372.07
14,965.47
Profit Before Tax
83,544.99
90,352.81
1,00,568.59
93,313.55
77,110.21
63,167.29
56,041.29
Tax
19,737.73
18,529.59
20,349.74
19,765.18
16,893.19
12,985.86
11,575.57
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
63,807.26
71,823.22
80,218.84
67,664.50
60,217.02
50,181.43
44,465.71
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
63,807.26
71,823.22
80,218.84
67,664.50
60,217.02
50,181.43
44,465.71
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
63,807.26
71,823.22
80,218.84
67,664.50
60,217.02
50,181.43
44,465.71
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
7,50,071.93
7,51,771.30
7,31,982.18
6,26,593.50
5,84,225.59
5,44,072.59
4,25,171.03
Earnings per share (EPS)
2889.38
3252.36
3971.57
3357.86
2987.22
3250.0
2904.05
Diluted Earnings per share
2889.38
3252.36
3971.57
3357.86
2987.22
3250.0
2904.05
Operating Profit Margin (Excl OI)
8.4%
8.76%
9.73%
9.0%
7.05%
8.69%
6.89%
Gross Profit Margin
11.52%
12.92%
12.57%
11.32%
12.01%
11.59%
11.47%
PAT Margin
6.47%
7.69%
7.87%
6.71%
7.67%
7.31%
7.18%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 5.47% vs -8.32% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -11.16% vs -10.47% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 0.46% vs -11.45% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -29.65% vs -46.12% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Vidipha Central Pharmaceutical JSC With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
9,85,636.69
0
9,85,636.69
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,85,636.69
0
9,85,636.69
Raw Material Cost
7,35,565.94
0
7,35,565.94
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,36,069.39
0
1,36,069.39
Power Cost
0
0
0.00
Manufacturing Expenses
10,446.77
0
10,446.77
Selling and Distribution Expenses
1,53,059.30
0
1,53,059.30
Other Expenses
-14,651.62
0.00
-14,651.62
Total Expenditure (Excl Depreciation)
8,88,625.24
0
8,88,625.24
Operating Profit (PBDIT) excl Other Income
97,011.45
0.00
97,011.45
Other Income
11,232.86
0
11,232.86
Operating Profit (PBDIT)
1,23,981.08
0
1,23,981.08
Interest
10,446.77
0
10,446.77
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
2,50,070.75
0
2,50,070.75
Depreciation
29,989.31
0
29,989.31
Profit Before Tax
83,544.99
0
83,544.99
Tax
19,737.73
0
19,737.73
Provisions and contingencies
0
0
0.00
Profit After Tax
63,807.26
0
63,807.26
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
63,807.26
0
63,807.26
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
63,807.26
0
63,807.26
Equity Capital
0
0
0.00
Face Value
10,000.00
0
0.00
Reserves
7,50,071.93
0
7,50,071.93
Earnings per share (EPS)
2,889.38
0
2,889.38
Diluted Earnings per share
2,889.38
0
2,889.38
Operating Profit Margin (Excl OI)
8.40%
0%
0.00
8.40%
Gross Profit Margin
11.52%
0%
0.00
11.52%
PAT Margin
6.47%
0%
0.00
6.47%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 98,563.67 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 5.47% vs -8.32% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 6,380.73 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -11.16% vs -10.47% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11,274.82 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 0.46% vs -11.45% in Dec 2024

Annual - Interest
Interest 1,044.68 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -29.65% vs -46.12% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.40%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024